Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nikita Makretsov"'
Autor:
Nikita Makretsov
Publikováno v:
International Journal of Surgical Oncology, Vol 2015 (2015)
Breast cancer mammographic screening leads to detection of premalignant and preinvasive lesions with an increasing frequency. Nevertheless, current epidemiologic evidence indicates that the screening reduces breast cancer specific mortality, but not
Externí odkaz:
https://doaj.org/article/3bc5ed06ee174c1b9b51b9ce7e56e4f1
Autor:
Nikita Makretsov
Publikováno v:
International Journal of User-Driven Healthcare. 3:49-63
This paper aims to help health care providers to advise the healthy female patients age of 40-49 y.o. who have one first degree relative with breast cancer, whether she should or should not participate in mammographic screening. The author’s patien
Autor:
Lindsay Brown, Nikita Makretsov, Blake Gilks, Hanna Kim, Jonathan R. Pollack, Teri A. Longacre, Julie A. Irving, David G. Huntsman, Robin L Parker, Stephen Chia, Joshua Z. Press, Anthony M. Magliocco
Publikováno v:
Gynecologic Oncology. 100:264-270
Objectives. Amplification of the 11q13 locus is commonly observed in a number of human cancers including both breast and ovarian cancer. Cyclin D1 and EMS1 have been implicated as candidate oncogenes involved in the emergence of amplification at this
Autor:
David G. Huntsman, Torsten O. Nielsen, Michael Peacock, Malcolm Hayes, Erika Yorida, Chris Bajdik, Maggie C.U. Cheang, Matt van de Rijn, Sandra E. Dunn, C. Blake Gilks, Nikita Makretsov
Publikováno v:
Clinical Cancer Research. 10:6143-6151
Prognostically relevant cluster groups, based on gene expression profiles, have been recently identified for breast cancers, lung cancers, and lymphoma. Our aim was to determine whether hierarchical clustering analysis of multiple immunomarkers (prot
Autor:
Jill E. Kucab, Valentina Evdokimova, Sandra E. Dunn, C. Blake Gilks, Christy Brookes, Torsten O. Nielsen, Leonard M. Neckers, Heather N. Andrews, David G. Huntsman, Nikita Makretsov, Forrest D. Hsu, Maggie C.U. Cheang, Joseph Ragaz, Chris Bajdik
Publikováno v:
Cancer Research. 64:286-291
Urokinase plasminogen activator (uPA) expression in breast cancer is associated with relapse and a reduction in disease-specific survival. Thus, efforts are under way to identify uPA inhibitors. By screening a chemical library of >1000 compounds, 17-
Publikováno v:
Human Pathology. 34:1001-1008
The aim of this study was to detect neuroendocrine differentiation (NE), to determine its association with major clinicopathological parameters of breast cancer, and to study the prognostic significance of NE differentiation in a group of breast carc
Publikováno v:
Maturitas. 73:177-179
Autor:
Nikita, Makretsov, C Blake, Gilks, Reza, Alaghehbandan, John, Garratt, Louise, Quenneville, Joel, Mercer, Dragana, Palavdzic, Emina E, Torlakovic
Publikováno v:
Archives of pathologylaboratory medicine. 135(7)
External quality assurance and proficiency testing programs for breast cancer predictive biomarkers are based largely on traditional ad hoc design; at present there is no universal consensus on definition of a standard reference value for samples use
Autor:
John F. Bechberger, Erika Yorida, Wun Chey Sin, David G. Huntsman, Christian C. Naus, Nikita Makretsov, Dmitry Turbin, Chris M.J. Conklin
Publikováno v:
Cancer letters. 255(2)
Breast cancer accounts for approximately 15% of all cancer deaths. Currently, axillary nodal status is the most reliable prognostic indicator for breast cancer. Tumor size and histological grade are used to stage breast cancer. Estrogen receptor/prog
Autor:
David G. Huntsman, Melinda A. Miller, Ronald J deLeeuw, Torsten O. Nielsen, Stephen Chia, Ashleen Shadeo, Leah M Prentice, Dmitry Turbin, John Bentley, Maggie C.U. Cheang, Valia S. Lestou, Erika Yorida, C. Blake Gilks, Nicol Macpherson, Wan L. Lam, Lindsay Brown, Nikita Makretsov
Publikováno v:
Oncogene. 24(49)
Rearrangements of the neuregulin (NRG1) gene have been implicated in breast carcinoma oncogenesis. To determine the frequency and clinical significance of NRG1 aberrations in clinical breast tumors, a breast cancer tissue microarray was screened for